Proteolytic pan-RAS Cleavage Leads to Tumor Regression in Patient-derived Pancreatic Cancer Xenografts

INIS

• pancreas 100%
• tumors 83%
• mutants 66%
• adenocarcinomas 66%
• patients 50%
• mice 33%
• cancer 33%
• levels 16%
• tissues 16%
• in vivo 16%
• comparative evaluations 16%
• management 16%
• control 16%
• architecture 16%
• fibrosis 16%
• inhibition 16%
• concentration 16%
• toxins 16%
• cell proliferation 16%
• switches 16%
• intraperitoneal injection 16%
• cleavage 16%

Medicine and Dentistry

• Pancreas Adenocarcinoma 66%
• Mutant 66%
• Neoplasm 50%
• Therapeutic Procedure 50%
• Biological Product 33%
• Xenograft 33%
• Cell Proliferation 33%
• Tumor Regression 33%
• Pancreas Cancer 33%
• Adenocarcinoma Cell Line 33%
• Patient 33%
• Toxin 16%
• Development 16%
• Serum 16%
• Tumor Xenograft 16%
• Cleft 16%
• Fibrosis 16%
• Antineoplastic Activity 16%
• Intraperitoneal Drug Administration 16%
• Tissues 16%
• Inpatient 16%
• Psychiatrist 16%